Suchergebnisse - "Li, Qingju"

PubPharm (37)

1

Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus : A 24-week, randomized, double-blind, active-controlled, phase 3 trial

enthalten in: Journal of diabetes | 2024

von Xie, L. | Han, J. | Cheng, Z. | +12

2

Berberine ameliorates contrast-induced acute kidney injury by regulating HDAC4-FoxO3a axis-induced autophagy : In vivo and in vitro

enthalten in: Phytotherapy research : PTR | 2024

von Zuo, Z. | Li, Q. | Zhou, S. | +8

3

Berberine alleviates contrast-induced nephropathy by activating Akt/Foxo3a/Nrf2 signalling pathway

enthalten in: Journal of cellular and molecular medicine | 2024

von Wang, W. | Yu, R. | Wu, C. | +7

4

Berberine alleviates contrast‐induced nephropathy by activating Akt/Foxo3a/Nrf2 signalling pathway

enthalten in: Journal of Cellular and Molecular Medicine | 2024

von Wang, W. | Yu, R. | Wu, C. | +7

5

Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus : A 24‐week, randomized, double‐blind, active‐controlled, phase 3 trial

enthalten in: Journal of Diabetes | 2024

von Xie, L. | Han, J. | Cheng, Z. | +12

6

Activation of Nrf2/ARE pathway by Anisodamine (654-2) for Inhibition of cellular aging and alleviation of Radiation-Induced lung injury

enthalten in: International immunopharmacology | 2023

von Guo, H. | Chen, J. | Yu, H. | +8

7

The clinical predictive value and regulation mechanism of microRNA-188-5p in contrast-induced acute kidney injury

enthalten in: Biochemical and biophysical research communications | 2023

von Yu, R. | Wu, C. | Xiao, Y. | +6

8

Exploring the impact of cognitive impairments on treatment compliance and quality of life in patients with Continuous Ambulatory Peritoneal Dialysis (CAPD)

enthalten in: Medicine | 2023

von Wu, C. | Yu, R. | Li, Q. | +2

9

Salvianolic Acid B Alleviates Myocardial Ischemia Injury by Suppressing NLRP3 Inflammasome Activation via SIRT1-AMPK-PGC-1α Signaling Pathway

enthalten in: Cardiovascular toxicology | 2022

von Li, Q. | Zuo, Z. | Pan, Y. | +3

10

Efficacy and safety benefits of iGlarLixi versus insulin glargine 100 U/mL or lixisenatide in Asian Pacific people with suboptimally controlled type 2 diabetes on oral agents : The LixiLan-O-AP randomized controlled trial

enthalten in: Diabetes, obesity & metabolism | 2022

von Yang, W. | Dong, X. | Li, Q. | +10